Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Int J Cardiol. 2016 Aug 2;222:361–367. doi: 10.1016/j.ijcard.2016.07.263

Fig. 4.

Fig. 4

Changes in dual-contrast CMR parameters of A13 and NS groups during the 4-week infusion period from weeks 1 to 5. A. DEMRI scar volume (% of LV myocardium) of A13 group decreased significantly when compared to the NS group (34.3% to 25.1%* vs. 33.8% to 29.8%, *p = 0.02), B. MEMRI defect volume (% of LV myocardium) of A13 group showed significant decrease when compared to the NS group (p = 0.05) and C. Peri-infarct volume (% of LV myocardium) of A13 group showed significant decrease when compared to NS group (15.1% to 7.4%* vs. 14.8% to 11.6%, *p = 0.02).